Delivery Order SPE2DB20D2104-SPE2DB25FMCRP

Award Date 11/21/24
Potential Completion Date 11/22/24
Potential Value $23K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The IDC, valued up to $999,999,999.00 through December 31, 2025, serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense (DoD) worldwide. The specific delivery order...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) under an Indefinite Delivery Contract (IDC) for $999,999,999 that runs through November 2026. The delivery order is for STELARA 90 MG/ML syringes, a specialty medication, with a ceiling value of $16,656.55 and a completion date of November 21, 2024. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition....
This is a delivery order award under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, who was awarded a $999,999,999 IDC with the DLA to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific $7,300.01 delivery order is for STELARA 90 MG/ML syringes. The contract has a...
This is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen Drug Corp (the prime contractor) and the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at up to $999,999,999 through December 2025, allows DLA to efficiently procure a comprehensive range of pharmaceutical and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical equipment, to support military treatment programs and...
This federal contract award to Amerisourcebergen Drug Corp (a major pharmaceutical distributor) is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical valued at $999,999,999. The contract covers a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas to support military...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the specialty medication Stelara 90 mg/ml syringe. The contract has a ceiling value of $10,530.54 and a completion date of June 29, 2022. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as the primary vehicle...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product, with a ceiling value of $51,614.77 and a performance period through December 18, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order under the DLA's Indefinite Delivery Contract (IDC) valued at $999,999,999, which runs through November 2026. The contract provides a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Stelara 90 mg/ml syringes. The contract has a firm fixed price of $90,663.72 and a period of performance through August 2, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range of pharmaceutical products and...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of STELARA 90MG/ML SYR 1S, a specialty medication. The contract has a Ceiling Value of $50,535.74 and an Ultimate Completion Date of July 26, 2023. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMCRP
    Delivery Order

This is a delivery order under a large Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $999,999,999, covers a broad range of pharmaceutical and medical supply products to support military healthcare programs globally.

The specific delivery order being referenced is for the supply of 90 mg/mL Stelara syringes, a specialty medication, with a ceiling value of $22,656.81. The contract is a firm fixed-price arrangement, with a completion date of November 22, 2024. There is no set-aside designation, indicating open competition for this award. As a long-standing vendor for federal healthcare programs, AmerisourceBergen plays a critical role in providing essential pharmaceutical and medical products to the U.S. military and other government beneficiaries.

Generated 2/27/25, 11:23 AM